{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:01:50Z","timestamp":1792195310599,"version":"4.4.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Population-based data for metabolic dysfunction\u2013associated steatotic liver disease (MASLD)\u2013related mortality trends and forecasts in the United States are limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine MASLD-related mortality trends in the United States from 2006 to 2023 and forecast mortality rates up to 2040 overall and in subgroups by age, sex, race and ethnicity, and urbanization.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional study used data from the National Vital Statistics System dataset. Data on deaths attributed to MASLD were obtained for adults aged 25 years and older from January 1, 2006, to December 31, 2023.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Trends were evaluated by average annual percentage change (AAPC) in age-standardized mortality rates (ASMRs) per 100\u202f000 persons, and mortality rates were forecasted to 2040 using projection models.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 27\u202f961 decedents aged 25 years and older with MASLD (15\u202f251 [54.5%] aged \u226565 years; 15\u202f450 [55.3%] female; 3373 [12.1%] Hispanic, 1480 [5.3%] non-Hispanic Black, and 21\u202f936 [78.5%] non-Hispanic White) were documented from 2006 to 2023. ASMRs rose from 0.25 to 1.27 per 100\u202f000 persons, with AAPCs increasing from 9.27% in 2006 to 2018 to 22.66% in 2018 to 2021, then decreasing to \u22121.23% from 2021 to 2023, leading to projected ASMRs of 2.24 per 100\u202f000 persons in 2040. There were significant differences in the increases of ASMRs by age, with those aged 65 years or older having the steepest rise (AAPC, 15.34%; 95% CI, 14.40%-16.32%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001; 45-64 years: 8.76%; 95% CI, 7.29%-10.22%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001; 25-44 years: 2.65%; 95% CI, 0.49%-4.86%;\n P<\/jats:italic>\n \u2009=\u2009.02) and a projected increase from 3.69 per 100\u202f000 persons in 2024 to 7.12 per 100\u202f000 persons in 2040. However, there was no significant difference in ASMRs by sex (AAPC among women: 11.24%; 95% CI, 10.09%-12.40%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001; AAPC among men: 11.04%; 95% CI, 9.56%-12.63%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). ASMRs rose for all major racial ethnic groups, with the highest ASMR increase observed for non-Hispanic White individuals (AAPC, 11.12%; 95% CI, 9.48%-12.83%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), followed by Hispanic (AAPC, 10.67%; 95% CI, 9.11%-12.26%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), non-Hispanic Black (AAPC, 9.20%; 95% CI, 7.32%-11.11%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and non-Hispanic Asian (AAPC, 7.97%; 95% CI, 4.66%-11.75%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) individuals, while the projected values for these 4 groups showed similar increasing trends to 2040. There were also significant differences in ASMRs by metropolitan categories overall, with the highest rise in nonmetropolitan areas (AAPC, 13.50%; 95% CI, 10.70%-16.32%;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study, MASLD-related mortality increased rapidly between 2006 and 2023 and was projected to rise over the next 20 years, with the largest disparities among those aged 65 years and older, among non-Hispanic White and Hispanic individuals, and among nonmetropolitan populations.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.16367","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:00:22Z","timestamp":1750158022000},"page":"e2516367","source":"Crossref","is-referenced-by-count":33,"title":["Projected Trends in Metabolic Dysfunction\u2013Associated Steatotic Liver Disease Mortality Through 2040"],"prefix":"10.1001","volume":"8","author":[{"given":"Xinrong","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sovann","family":"Linden","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California"},{"name":"Department of Management Science and Engineering, School of Engineering, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Levesley","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California"},{"name":"Department of Biology, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpeng","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Mathematics and Statistics, Xi\u2019an Jiaotong University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Barnet","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsey","family":"Cheung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California"},{"name":"Veterans Affairs Palo Alto Health Care System, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanpu","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Second Affiliated Hospital of Xi\u2019an Jiaotong University, Xi\u2019an, China"},{"name":"Key Laboratory of Environment and Genes Related to Diseases, Xi\u2019an, Jiaotong University, Ministry of Education of China, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindie H.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, School of Medicine, Stanford University Medical Center, Palo Alto, California"},{"name":"Department of Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, California"},{"name":"Stanford Cancer Institute, Stanford University Medical Center, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"12","key":"zoi250515r1","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis.","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"zoi250515r2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"zoi250515r3","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000207","article-title":"Increasing nonalcoholic fatty liver disease-related mortality rates in the United States from 1999 to 2022.","volume":"7","author":"Ilyas","year":"2023","journal-title":"Hepatol Commun"},{"issue":"3","key":"zoi250515r4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review.","volume":"32","author":"Chan","year":"2023","journal-title":"J Obes Metab Syndr"},{"issue":"3","key":"zoi250515r5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).","volume":"81","author":"European Association for the Study of the Liver (EASL)","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"zoi250515r6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/hep.32633","article-title":"Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease.","volume":"77","author":"Lin","year":"2023","journal-title":"Hepatology"},{"issue":"5","key":"zoi250515r7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/hep.32476","article-title":"Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease.","volume":"76","author":"Zhang","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"zoi250515r8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12072-018-09926-z","article-title":"Race\/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016.","volume":"13","author":"Kim","year":"2019","journal-title":"Hepatol Int"},{"issue":"6","key":"zoi250515r9","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/joim.13035","article-title":"Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011-2016.","volume":"287","author":"Le","year":"2020","journal-title":"J Intern Med"},{"issue":"2","key":"zoi250515r10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the united states: a systematic review and meta-analysis.","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"zoi250515r11","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1111\/liv.15910","article-title":"Sex differences in mortality and liver-related events in non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"44","author":"Zhou","year":"2024","journal-title":"Liver Int"},{"issue":"2","key":"zoi250515r12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.31040","article-title":"Attributable fractions of nonalcoholic fatty liver disease for mortality in the United States: results from the third National Health and Nutrition Examination Survey with 27 years of follow-up.","volume":"72","author":"Alvarez","year":"2020","journal-title":"Hepatology"},{"issue":"11","key":"zoi250515r13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the United States.","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"issue":"1","key":"zoi250515r14","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41598-022-26406-5","article-title":"Urbanization and physical activity in the global Prospective Urban and Rural Epidemiology study.","volume":"13","author":"Boakye","year":"2023","journal-title":"Sci Rep"},{"key":"zoi250515r15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.850872","article-title":"The effect of urbanization on health care expenditure: evidence from China.","volume":"10","author":"Shao","year":"2022","journal-title":"Front Public Health"},{"issue":"6","key":"zoi250515r16","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"zoi250515r17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.14218\/JCTH.2022.00313","article-title":"Trends of cirrhosis-related mortality in the USA during the COVID-19 pandemic.","volume":"11","author":"Yeo","year":"2023","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"zoi250515r18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"zoi250515r19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3350\/cmh.2023.0485","article-title":"Global incidence of adverse clinical events in non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"30","author":"Le","year":"2024","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"zoi250515r20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons.","volume":"79","author":"Le","year":"2023","journal-title":"J Hepatol"},{"issue":"4","key":"zoi250515r21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","article-title":"Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach.","volume":"28","author":"Le","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"zoi250515r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101193","article-title":"Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD.","volume":"6","author":"Pustjens","year":"2024","journal-title":"JHEP Rep"},{"issue":"12","key":"zoi250515r23","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1136\/gutjnl-2023-330269","article-title":"Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial.","volume":"72","author":"Zhang","year":"2023","journal-title":"Gut"},{"issue":"5","key":"zoi250515r24","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease.","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"issue":"8","key":"zoi250515r25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD.","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"zoi250515r26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hep4.1285","article-title":"Prevalence of nonalcoholic fatty liver disease in the female population.","volume":"3","author":"Arshad","year":"2018","journal-title":"Hepatol Commun"},{"issue":"1","key":"zoi250515r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.51070","article-title":"General or central obesity and mortality among US Hispanic and Latino adults.","volume":"7","author":"Zhang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi250515r28","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2020.01.029","article-title":"A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.","volume":"72","author":"Walker","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"zoi250515r29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.6370","article-title":"Joint associations of race, ethnicity, and socioeconomic status with mortality in the Multiethnic Cohort Study.","volume":"5","author":"Sangaramoorthy","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi250515r30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"zoi250515r31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3350\/cmh.2023.0205","article-title":"Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: a longitudinal real-world study.","volume":"29","author":"Nguyen","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"zoi250515r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100220","article-title":"Prevalence and associated factors for non-alcoholic fatty liver disease among adults in the South Asian region: a meta-analysis.","volume":"15","author":"Niriella","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"3","key":"zoi250515r33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD.","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"zoi250515r34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jrh.12335","article-title":"Differences in rural and urban health information access and use.","volume":"35","author":"Chen","year":"2019","journal-title":"J Rural Health"},{"issue":"9","key":"zoi250515r35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.32318","article-title":"Assessment of disparities in diabetes mortality in adults in US rural vs nonrural counties, 1999-2018.","volume":"5","author":"Dugani","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi250515r36","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.22605\/RRH3267","article-title":"Obesity and obesity-related behaviors among rural and urban adults in the USA.","volume":"15","author":"Trivedi","year":"2015","journal-title":"Rural Remote Health"},{"issue":"1","key":"zoi250515r37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000572","article-title":"Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM.","volume":"8","author":"Hayward","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"10","key":"zoi250515r38","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/hep4.1408","article-title":"Nonalcoholic fatty liver disease and renal function impairment: a cross-sectional population-based study on its relationship from 1999 to 2016.","volume":"3","author":"Le","year":"2019","journal-title":"Hepatol Commun"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2835403\/zhang_2025_oi_250515_1749568847.62248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T11:00:23Z","timestamp":1750158023000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2835403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.16367","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}